共 50 条
- [33] Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab European Journal of Pediatrics, 2022, 181 : 539 - 547
- [34] Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (04):
- [37] Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (04): : 216 - 223